The acceleration of the application of health and medical big data has brought positive benefits to the mobile medical industry. The General Office of the State Council recently issued the "Guiding Opinions on Promoting and Standardizing the Development of Health and Medical Big Data Application" (hereinafter referred to as the "Opinions"), which pointed out that laws and regulations such as opening and protection of health and medical big data will be established and improved; by the end of 2017, a pattern of sharing and sharing of cross-departmental health and medical data resources will be basically formed. Industry insiders predict that online prescription drugs will usher in the dawn of lifting the ban in 2018.
Health and medical big data is regarded as an important measure to stimulate deepen the reform of the medical and health system. The opinions propose that the construction and improvement of basic databases with residents' electronic health records, electronic medical records, electronic prescriptions, etc. as the core will be accelerated. All types of medical and health institutions are encouraged to promote the collection and storage of health and medical big data, strengthen application support and operation and maintenance technical guarantees, and open up data resource sharing channels. By the end of 2017, the national and provincial population health information platforms and the national drug bidding and procurement business application platforms will be interconnected, and a pattern of sharing and sharing of cross-departmental health and medical data resources will be basically formed.
Building a health care big data sharing platform is of great significance to the mobile medical and pharmaceutical e-commerce industries. In the current medical industry, prescription information is mostly in the hands of the hospital and needs to be prescribed by a practicing pharmacist. A person in charge of a pharmaceutical e-commerce platform said that if electronic prescription sharing can be realized, it will mean that hospital prescriptions are outflows, which is a huge bonus for mobile medical companies. At the same time, the opinions on standardizing the application of health and medical big data have also sent a positive signal to the pharmaceutical e-commerce industry. With the formation of a cross-departmental health and medical data resource sharing pattern, this may promote the accelerated lifting of the ban on online sales of prescription drugs.
Sales of prescription drugs have always been a "forbidden zone" that most pharmaceutical e-commerce companies are difficult to reach. According to the "Internet Food and Drug Administration Supervision and Administration Measures (Draft for Comments)" published by the State Food and Drug Administration in 2014, Internet drug operators shall sell prescription drugs based on prescriptions in accordance with the requirements of drug classification management regulations. The regulation is regarded by the industry as the basis for prescription drugs to be sold online, but in the past two years, online prescription drugs have not made breakthrough progress.
A researcher in the field of medicine said that once electronic prescriptions are released, the most intuitive benefit is that people can buy medicine outside pharmacies, online and other places to avoid long queues in hospitals based on electronic prescriptions issued by doctors.
In fact, with the accelerated implementation of new medical reform, some chain pharmacies have begun to explore innovative models through joining Internet companies. Previously, Laobaixing Pharmacy reached a cooperation with the Internet hospital platform WeDoctor to seize the prescription drug market through the pharmacy + online consultation model.
EN
CN
